Food & Drug Administration (2021) FDA approves first generic of once-daily GLP-1 injection to lower blood sugar in patients with type 2 diabetes, U.S
Canagliflozin triggers the FGF23/1,25-dihydroxyvitamin D/PTH axis in healthy volunteers in a randomized crossover study
Because results build gradually, consistent use over several months is generally recommended before expecting noticeable improvements in the appearance of skin texture, firmness, or fine lines
That last point is the one that changes daily life the most, so let us start there
[The question] is just whether or not increasing them synthetically is safe or not. There are several well-studied, FDA-approved peptides available today, such as insulin and GLP-1s like Ozempic and Wegovy, but thats just a sliver of the peptide pie